Harvard Bioscience (HBIO) Cash from Operations Growth (1y) (2011 - 2026)
Harvard Bioscience (HBIO) Cash from Operations Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 127.11 Bn | 121.89 Bn | 1.96 Bn | 48.31% |
| 2 | Becton Dickinson | 44.95 Bn | 44.14 Bn | 2.15 Bn | 428.92% |
| 3 | Alcon | 33.17 Bn | 31.51 Bn | 1.53 Bn | - |
| 4 | Medline | 32.85 Bn | 30.61 Bn | 1.84 Bn | -39.59% |
| 5 | Resmed | 29.48 Bn | 27.82 Bn | 890.98 Mn | -4.24% |
| 6 | West Pharmaceutical Services | 23.33 Bn | 22.89 Bn | 329.20 Mn | -29.98% |
| 7 | Solventum | 14.10 Bn | 13.54 Bn | 1.10 Bn | -751.72% |
| 8 | Cooper Companies | 13.83 Bn | 13.69 Bn | 735.40 Mn | 90.02% |
| 9 | Align Technology | 12.05 Bn | 10.99 Bn | 736.59 Mn | 186.74% |
| 10 | Harvard Bioscience | 26.84 Mn | 19.74 Mn | 12.24 Mn | -122.17% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -122.17% |
| Dec 31, 2025 | -105.57% |
| Sep 30, 2025 | 228.74% |
| Jun 30, 2025 | 425.65% |
| Mar 31, 2025 | 112.83% |
| Dec 31, 2024 | -59.91% |
| Sep 30, 2024 | -119.31% |
| Jun 30, 2024 | -123.82% |
| Mar 31, 2024 | -22.57% |
| Dec 31, 2023 | 60.62% |
| Sep 30, 2023 | 571.96% |
| Jun 30, 2023 | 1,969.47% |
| Mar 31, 2023 | 191.24% |
| Dec 31, 2022 | 2,189.74% |
| Sep 30, 2022 | 198.33% |
| Jun 30, 2022 | -124.74% |
| Mar 31, 2022 | -291.51% |
| Dec 31, 2021 | -95.30% |
| Sep 30, 2021 | -141.33% |
| Jun 30, 2021 | -67.64% |